Switch to race-neutral equation would affect millions of U.S. kidney patients: study
By
Alicia Lasek
Feb 16, 2022
A highly recommended transition away from race-based measurements of kidney function resulted in new kidney disease classifications for 5.5 million patients in an analysis of 39,000, investigators say.
Genetic risk for obesity ups likelihood of kidney disease
Feb 08, 2022
Findings largely independent of blood pressure and type 2 diabetes
Dietary protein often too high in seniors with kidney disease, nephrologists say
By
Alicia Lasek
Jan 26, 2022
Study results underscore the need for a thorough nutritional review and intervention in this population, investigators say.
Adopt new test, and take race out of kidney disease diagnostics, clinicians urged
By
Alicia Lasek
Sep 24, 2021
Fewer Black patients will be left unaware of their true kidney function status if their healthcare providers switch to a diagnostic test that doesn’t rely on a race variable, according to a new report...
Post-acute kidney sequelae studied in COVID-19 survivors
Sep 07, 2021
Graded increase seen in risks for kidney outcomes according to the severity of the acute infection
Chronic kidney disease may be overdiagnosed in elderly; experts urge change
By
Alicia Lasek
Aug 31, 2021
Many elderly are being diagnosed and treated for a condition that will never cause symptoms or hasten death, a new study suggests. The current threshold for CKD diagnosis needs to change, investigators...
Post-acute provider launches comprehensive kidney disease program
By
Alicia Lasek
Aug 05, 2021
Services and therapies will include diabetes management, a full-time respiratory therapist and health coaching with the aim to preserve remaining kidney function. Dialysis will be added as well.
Monoclonal antibodies cut COVID-19 hospitalizations in high-risk adults: Mayo Clinic
By
Alicia Lasek
Jul 22, 2021
Patients treated early in the disease with either one of two antibody therapies had similarly low rates of hospitalization within 28 days.
Diabetes med Farxiga gets FDA nod as kidney failure treatment; drug cuts risk by 39 percent
By
Alicia Lasek
May 04, 2021
Farxiga, an SGLT2 inhibitor, was found to reduce the risk of worsening renal function or cardiovascular or renal death by 39% in patients with chronic kidney disease — with and without type 2 diabetes.
New blood pressure target for kidney patients could impact millions, experts say
By
Alicia Lasek
Feb 24, 2021
An estimated 24 million Americans with chronic kidney disease are candidates for intensive blood pressure control under new guidelines from Kidney Disease: Improving Global Outcomes, say Johns Hopkins...